Viatris
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Viatris and other ETFs, options, and stocks.About VTRS
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare.
CEOScott Andrew Smith
CEOScott Andrew Smith
Employees32,000
Employees32,000
HeadquartersCanonsburg, Pennsylvania
HeadquartersCanonsburg, Pennsylvania
Founded2019
Founded2019
Employees32,000
Employees32,000
VTRS Key Statistics
Market cap15.38B
Market cap15.38B
Price-Earnings ratio-4.32
Price-Earnings ratio-4.32
Dividend yield3.79%
Dividend yield3.79%
Average volume9.21M
Average volume9.21M
High today$13.48
High today$13.48
Low today$12.53
Low today$12.53
Open price$12.68
Open price$12.68
Volume15.59M
Volume15.59M
52 Week high$13.48
52 Week high$13.48
52 Week low$6.85
52 Week low$6.85
Stock Snapshot
As of today, Viatris(VTRS) shares are valued at $13.43. The company's market cap stands at 15.38B, with a P/E ratio of -4.32 and a dividend yield of 3.8%.
On 2026-01-14, Viatris(VTRS) stock moved within a range of $12.53 to $13.48. With shares now at $13.43, the stock is trading +7.2% above its intraday low and -0.4% below the session's peak.
Trading volume for Viatris(VTRS) stock has reached 15.59M, versus its average volume of 9.21M.
The stock's 52-week range extends from a low of $6.85 to a high of $13.48.
The stock's 52-week range extends from a low of $6.85 to a high of $13.48.
Analyst ratings
50%
of 12 ratingsBuy
33.3%
Hold
50%
Sell
16.7%
People also own
Based on the portfolios of people who own VTRS. This list is generated using Robinhood data, and it’s not a recommendation.